By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gentel Biosciences today said that it has acquired the SilverQuant trademark from Eppendorf, which it will apply to its protein array technology platform.

Madison, Wis.-based Gentel said the acquisition of the trademark complements its other initiatives to grow its market position as a provider of multiplexed proteomic tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.